La espirometría forzada de calidad en Atención Primaria, impacto en el tratamiento de la EPOC;Quality of Forced Spirometry in Primary Care, Impact on the COPD Treatment

Archivos de Bronconeumologia

Volumn 47, Issue 5, 2011, Pages 224-225

  Burgos, Felip ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; PRIMARY MEDICAL CARE; QUALITY CONTROL; SPIROMETRY; HUMAN; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; STANDARD;

HUMANS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 79955742197     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.03.001     Document Type: Article

References (13)

1. Mannino D.M., Buist S.A., Petty T.L., Enright P.L., Redd C.S. Lung function and mortality in the United Status: data from the First Matinal Health and Nutritional Examination Survey follow-up study. Thorax 2003, 58:388-393.
2. Burney P.G.J., Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011, 66:49-54.
3. Lee H.M., Le H., Lee B.T., López V.A., Wong N.D. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010, 36:1002-1006.
4. Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Durán-Tauleria E., Muñoz L., et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010, 36:758-765.
5. Naberan K., de la Roza C., Lamban M., Gobartt E., Martín A., Miravitlles M. Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol 2006, 42:638-644.
6. Castillo D., Guayta R., Giner J., Burgos F., Capdevila C., Soriano J.B., et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med 2009, 103:839-845. FARMAEPOC group.
7. Dales R.E., Vandemheen K.L., Clinch J., Aaron S.D. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest 2005, 128:2443-2447.
8. Monteagudo M., et al. Variabilidad en la realización de la espirometría y sus consecuencias en el tratamiento de la EPOC en Atención Primaria. Archiv Bronconeumol. 2011, 47:226-233.
9. Pellicer C., Soler-Cataluña J.J., Andreu A., Bueso J. Calidad del diagnóstico de la enfermedad pulmonar obstructiva crónica en el ámbito hospitalario. Arch Bronconeumol 2010, 46:64-69.
10. Soler-Cataluña J.J., Calle M., Cosío B.G., Marín J.M., Monsó E., Alfageme I. Estándares de calidad asistencial en la EPOC. Arch Bronconeumol 2009, 45:196-203. Comité de Calidad Asistencial de la SEPAR; Area de Trabajo EPOC de la SEPAR.
11. Peces-Barba G, Barberà JA, Agustí AGN, Casanova C, et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Disponible en: http://www.separ.es/publicaciones/normativas.html. Arch Bronconeumol. 2008;44:271-8.
12. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276. GOLD Scientific Committee.
13. Telemetric developments in respiratory monitoring. J. Roca, B. Vallespín, F. Burgos. The Buyers' Guide to Respiratory Care Products, 2008.